Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,580.00 ILa | +0.49% |
|
-1.59% | -5.05% |
| 07-09 | Teva Pharmaceuticals Obtains Rights to Commercialize Polpharma's Biosimilar Candidate to Ocrevus | MT |
| 07-09 | Teva, Samsung Bioepis Partner to Commercialize Eylea Biosimilar Opuviz in Canada | MT |
| Market Cap | 36.31B 0 31.89B 29.66B 27.21B 51.13B 3,496B 51.92B 352B 138B 1,719B 136B 133B 5,943B | P/E 2026 * |
38.5x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 47.47B 0 41.69B 38.77B 35.58B 66.85B 4,571B 67.88B 460B 180B 2,247B 178B 174B 7,771B | EV / Sales 2026 * |
2.85x | EV / Sales 2027 * | 2.59x |
| Free-Float |
88.61% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Teva Pharmaceutical Industries Limited
| 1 day | +0.49% | ||
| 1 week | -1.59% | ||
| Current month | -2.61% | ||
| 1 month | -4.20% | ||
| 3 months | +3.34% | ||
| 6 months | -3.33% | ||
| Current year | -5.05% |
| 1 week | 9,396 |  | 9,930 |
| 1 month | 9,396 | | 10,730 |
| Current year | 8,860 | | 11,350 |
| 1 year | 5,305 | | 11,350 |
| 3 years | 3,002 | | 11,350 |
| 5 years | 2,383 | | 11,350 |
| 10 years | 2,175 | | 21,200 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 01/01/2023 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 22/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 03/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 01/01/2009 |
Sol Barer
CHM | Chairman | 78 | 06/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 01/09/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | -1.59% | - | - | 36.31B | |
| +0.44% | +1.16% | +48.09% | +159.68% | 1,057B | |
| +1.47% | +3.88% | +55.02% | +53.64% | 624B | |
| +0.56% | +1.47% | +35.32% | +80.36% | 454B | |
| +1.60% | +6.25% | +33.95% | +29.84% | 341B | |
| -0.60% | +1.52% | +35.68% | +39.76% | 297B | |
| -0.14% | +0.60% | +16.17% | +17.53% | 262B | |
| +0.09% | -2.82% | -28.29% | -41.71% | 215B | |
| +1.26% | +2.59% | +21.79% | +59.63% | 201B | |
| -0.75% | -3.39% | +14.60% | +67.05% | 162B | |
| Average | +0.50% | +0.77% | +25.82% | +51.75% | 401.55B | |
| Weighted average by Cap. | +0.64% | +1.57% | +35.50% | +77.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.64B 0 14.61B 13.59B 12.47B 23.43B 1,602B 23.79B 161B 63.04B 788B 62.45B 61.11B 2,723B | 17.23B 0 15.14B 14.08B 12.92B 24.27B 1,659B 24.64B 167B 65.3B 816B 64.69B 63.3B 2,821B |
| Net income | 1.31B 0 1.15B 1.07B 981M 1.84B 126B 1.87B 12.7B 4.96B 61.98B 4.91B 4.81B 214B | 2.46B 0 2.16B 2.01B 1.85B 3.47B 237B 3.52B 23.9B 9.34B 117B 9.25B 9.05B 403B |
| Net Debt | 11.16B 0 9.8B 9.12B 8.37B 15.72B 1,075B 15.96B 108B 42.3B 528B 41.9B 41B 1,827B | 8.41B 0 7.38B 6.87B 6.3B 11.84B 810B 12.02B 81.53B 31.85B 398B 31.56B 30.88B 1,376B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | ILA 9,580.00 | +0.49% | 1,325,339 |
| 22/07/26 | ILA 9,533.00 | -0.88% | 1,061,041 |
| 21/07/26 | ILA 9,618.00 | -0.25% | 1,288,336 |
| 20/07/26 | ILA 9,642.00 | -0.96% | 759,073 |
| 17/07/26 | ILA 9,735.00 | -0.41% | 485,235 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
